Interleukin-21: basic biology and implications for cancer and autoimmunity
- PMID: 17953510
- DOI: 10.1146/annurev.immunol.26.021607.090316
Interleukin-21: basic biology and implications for cancer and autoimmunity
Abstract
Interleukin-21 (IL-21), a potent immunomodulatory four-alpha-helical-bundle type I cytokine, is produced by NKT and CD4(+) T cells and has pleiotropic effects on both innate and adaptive immune responses. These actions include positive effects such as enhanced proliferation of lymphoid cells, increased cytotoxicity of CD8(+) T cells and natural killer (NK) cells, and differentiation of B cells into plasma cells. Conversely, IL-21 also has direct inhibitory effects on the antigen-presenting function of dendritic cells and can be proapoptotic for B cells and NK cells. IL-21 is also produced by Th17 cells and is a critical regulator of Th17 development. The regulatory activity of IL-21 is modulated by the differentiation state of its target cells as well as by other cytokines or costimulatory molecules. IL-21 has potent antitumor activity but is also associated with the development of autoimmune disease. IL-21 transcription is dependent on a calcium signal and NFAT sites, and IL-21 requires Stat3 for its signaling. The key to harnessing the power of IL-21 will depend on better understanding its range of biological actions, its mechanism of action, and the molecular basis of regulation of expression of IL-21 and its receptor.
Similar articles
-
The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer.Curr Opin Immunol. 2008 Jun;20(3):295-301. doi: 10.1016/j.coi.2008.02.004. Epub 2008 Jun 12. Curr Opin Immunol. 2008. PMID: 18554883 Free PMC article. Review.
-
IL-21 in the pathogenesis and treatment of skin diseases.J Dermatol Sci. 2010 Nov;60(2):61-6. doi: 10.1016/j.jdermsci.2010.08.016. Epub 2010 Sep 15. J Dermatol Sci. 2010. PMID: 20888735 Review.
-
IL-21: roles in immunopathology and cancer therapy.Tissue Antigens. 2009 Dec;74(6):467-79. doi: 10.1111/j.1399-0039.2009.01382.x. Epub 2009 Oct 21. Tissue Antigens. 2009. PMID: 19845910 Review.
-
Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.Immunobiology. 2016 Feb;221(2):357-67. doi: 10.1016/j.imbio.2015.09.021. Epub 2015 Oct 1. Immunobiology. 2016. PMID: 26466984 Review.
-
Interleukin-21 signaling: functions in cancer and autoimmunity.Clin Cancer Res. 2007 Dec 1;13(23):6926-32. doi: 10.1158/1078-0432.CCR-07-1238. Clin Cancer Res. 2007. PMID: 18056166 Review.
Cited by
-
HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cells.AIDS. 2021 Jul 1;35(8):1167-1177. doi: 10.1097/QAD.0000000000002864. AIDS. 2021. PMID: 33710028 Free PMC article.
-
IL-6 activated integrated BATF/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapy.Sci Rep. 2013;3:1754. doi: 10.1038/srep01754. Sci Rep. 2013. PMID: 23628948 Free PMC article.
-
Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B.J Leukoc Biol. 2017 Feb;101(2):567-576. doi: 10.1189/jlb.4A0616-271R. Epub 2016 Aug 26. J Leukoc Biol. 2017. PMID: 27566831 Free PMC article.
-
Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes.Curr Opin Immunol. 2012 Aug;24(4):364-78. doi: 10.1016/j.coi.2012.04.011. Epub 2012 May 30. Curr Opin Immunol. 2012. PMID: 22651901 Free PMC article. Review.
-
Highly tailorable gellan gum nanoparticles as a platform for the development of T cell activator systems.Biomater Res. 2022 Sep 30;26(1):48. doi: 10.1186/s40824-022-00297-z. Biomater Res. 2022. PMID: 36180901 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous